There will be no new trial for GlaxoSmithKline in connection with the death of Reed Smith partner Stewart Dolin in 2010, a federal judge in Chicago ruled last week.

The company, which was hit with a $3 million verdict earlier this year, was sued by the widow of Stewart Dolin, who threw himself in front of an “L” train shortly after he began taking a generic version of GSK's antidepressant Paxil.

Most of the lawsuit centered on the drug label: Were the warnings about the risk of self-harm adequate?

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Go To Lexis →

Not a Lexis Subscriber?
Subscribe Now

Go To Bloomberg Law →

Not a Bloomberg Law Subscriber?
Subscribe Now

NOT FOR REPRINT